share_log

B of A Securities Maintains Buy on Cellebrite DI, Raises Price Target to $13

Moomoo 24/7 ·  Apr 1 07:12

B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $12 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment